114 related articles for article (PubMed ID: 26367731)
1. Rapamycin inhibits the proliferation of SW1990 pancreatic cancer cell.
Xu M; Bu LM; Wu K; Lu LG; Wang XP
Eur Rev Med Pharmacol Sci; 2015 Aug; 19(16):3072-9. PubMed ID: 26367731
[TBL] [Abstract][Full Text] [Related]
2. A study on the mechanism of rapamycin mediating the sensitivity of pancreatic cancer cells to cisplatin through PI3K/AKT/mTOR signaling pathway.
Li B; Yang J; Lu Z; Liu B; Liu F
J BUON; 2019; 24(2):739-745. PubMed ID: 31128031
[TBL] [Abstract][Full Text] [Related]
3. Sirolimus inhibits human pancreatic carcinoma cell proliferation by a mechanism linked to the targeting of mTOR/HIF-1 alpha/VEGF signaling.
Wang Y; Zhao Q; Ma S; Yang F; Gong Y; Ke C
IUBMB Life; 2007 Nov; 59(11):717-21. PubMed ID: 17968710
[TBL] [Abstract][Full Text] [Related]
4. [Effects of mTOR Inhibitor Rapamycin on Burkitt's Lymphoma Cells].
Zhou LH; Zhu XP; Xiao HF; Xin PL; Li CT
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1397-1405. PubMed ID: 29070114
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin provides a therapeutic option through inhibition of mTOR signaling in chronic myelogenous leukemia.
Li J; Xue L; Hao H; Han Y; Yang J; Luo J
Oncol Rep; 2012 Feb; 27(2):461-6. PubMed ID: 21993902
[TBL] [Abstract][Full Text] [Related]
6. [Synergistic effect of rapamycin (RPM) and PD98059 on cell cycle and mTOR signal transduction in human colorectal cancer cells].
Zhang YJ; Fang JY; Sun DF; Zhao SL; Shen GF; Zheng Q; Zhu HY
Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):889-93. PubMed ID: 18478925
[TBL] [Abstract][Full Text] [Related]
7. FRAP-p70s6K signaling is required for pancreatic cancer cell proliferation.
Shah SA; Potter MW; Ricciardi R; Perugini RA; Callery MP
J Surg Res; 2001 May; 97(2):123-30. PubMed ID: 11341787
[TBL] [Abstract][Full Text] [Related]
8. Cucurmosin induces apoptosis of BxPC-3 human pancreatic cancer cells via inactivation of the EGFR signaling pathway.
Zhang B; Huang H; Xie J; Xu C; Chen M; Wang C; Yang A; Yin Q
Oncol Rep; 2012 Mar; 27(3):891-7. PubMed ID: 22139427
[TBL] [Abstract][Full Text] [Related]
9. Targeting mTOR/p70S6K/glycolysis signaling pathway restores glucocorticoid sensitivity to 4E-BP1 null Burkitt Lymphoma.
Gu L; Xie L; Zuo C; Ma Z; Zhang Y; Zhu Y; Gao J
BMC Cancer; 2015 Jul; 15():529. PubMed ID: 26189041
[TBL] [Abstract][Full Text] [Related]
10. [Blockage of mTOR signaling pathway by rapamycin contributes to inhibition of tumor cell proliferation in ALK-positive lymphoid cell strains].
Gu L; Li JF; Gao J; Zhu YP; Li Q; Jia CS; Zhou CY; Ma ZG
Zhonghua Xue Ye Xue Za Zhi; 2008 Oct; 29(10):662-6. PubMed ID: 19176057
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin and CCI-779 inhibit the mammalian target of rapamycin signalling in hepatocellular carcinoma.
Hui IC; Tung EK; Sze KM; Ching YP; Ng IO
Liver Int; 2010 Jan; 30(1):65-75. PubMed ID: 19845851
[TBL] [Abstract][Full Text] [Related]
12. [Inhibitory effects of rapamycin on proliferation of chronic myelogenous leukemia cells and its mechanism].
Li J; Xue LY; Han YX; Shang YT; Yao L; Luo JM
Zhonghua Xue Ye Xue Za Zhi; 2012 Oct; 33(10):843-6. PubMed ID: 23384908
[TBL] [Abstract][Full Text] [Related]
13. Pseudomonas aeruginosa-mannose-sensitive hemagglutinin inhibits pancreatic cancer cell proliferation and induces apoptosis via the EGFR pathway and caspase signaling.
Cheng X; Wang B; Jin Z; Ma D; Yang W; Zhao R; Jing X; Shen B; Peng C; Qiu W
Oncotarget; 2016 Nov; 7(47):77916-77925. PubMed ID: 27788491
[TBL] [Abstract][Full Text] [Related]
14. [In vitro study of effects and mechanism of rapamycin-induced autophagy in keloid fibroblasts].
Gao J; Jiao H; Cao R; Yang Z; Sun X; Zhuang Q; Xiao Z; Yan Z
Zhonghua Zheng Xing Wai Ke Za Zhi; 2016 May; 32(3):208-14. PubMed ID: 30044067
[TBL] [Abstract][Full Text] [Related]
15. [Inhibitory effect and significance of rapamycin on the mammalian target of rapamycin signaling pathway in osteosarcoma stem cells and osteosarcoma cells].
Liu PY; Zhang WB; Wang J; Shen YH; Wei YY
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):175-80. PubMed ID: 23879996
[TBL] [Abstract][Full Text] [Related]
16. CdSe/ZnS quantum dots induce photodynamic effects and cytotoxicity in pancreatic cancer cells.
He SJ; Cao J; Li YS; Yang JC; Zhou M; Qu CY; Zhang Y; Shen F; Chen Y; Li MM; Xu LM
World J Gastroenterol; 2016 Jun; 22(21):5012-22. PubMed ID: 27275093
[TBL] [Abstract][Full Text] [Related]
17. Numb/Notch signaling pathway modulation enhances human pancreatic cancer cell radiosensitivity.
Bi YL; Min M; Shen W; Liu Y
Tumour Biol; 2016 Nov; 37(11):15145-15155. PubMed ID: 27677287
[TBL] [Abstract][Full Text] [Related]
18. Effect of rapamycin alone and in combination with antiangiogenesis therapy in an orthotopic model of human pancreatic cancer.
Stephan S; Datta K; Wang E; Li J; Brekken RA; Parangi S; Thorpe PE; Mukhopadhyay D
Clin Cancer Res; 2004 Oct; 10(20):6993-7000. PubMed ID: 15501979
[TBL] [Abstract][Full Text] [Related]
19. The rapamycin-sensitive signal transduction pathway as a target for cancer therapy.
Hidalgo M; Rowinsky EK
Oncogene; 2000 Dec; 19(56):6680-6. PubMed ID: 11426655
[TBL] [Abstract][Full Text] [Related]
20. Antiproliferative effect of rapamycin on human T-cell leukemia cell line Jurkat by cell cycle arrest and telomerase inhibition.
Zhao YM; Zhou Q; Xu Y; Lai XY; Huang H
Acta Pharmacol Sin; 2008 Apr; 29(4):481-8. PubMed ID: 18358095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]